BNTX icon

BioNTech

300 hedge funds and large institutions have $5.78B invested in BioNTech in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 84 increasing their positions, 85 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

2% more funds holding

Funds holding: 294300 (+6)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

1% less repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 85

Holders
300
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$373M
Puts
$269M
Net Calls
Net Calls Change

Top Buyers

1 +$160M
2 +$102M
3 +$70M
4
DZ Bank
DZ Bank
Germany
+$49.4M
5
UBS Group
UBS Group
Switzerland
+$46.3M

Top Sellers

1 -$73.7M
2 -$43M
3 -$29.9M
4
Primecap Management
Primecap Management
California
-$25.1M
5
BlackRock
BlackRock
New York
-$24.6M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$2.31M
102
$2.22M
103
$2.21M
104
$2.16M
105
$2.12M
106
$2.05M
107
$1.96M
108
$1.93M
109
$1.83M
110
$1.71M
111
$1.68M
112
$1.58M
113
$1.57M
114
$1.52M
115
$1.36M
116
$1.26M
117
$1.25M
118
$1.15M
119
$1.13M
120
$1.13M
121
$1.13M
122
$1.05M
123
$1.03M
124
$1.01M
125
$999K